Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal
Last week’s €1.75B deal between the German biotech Affimed and Swiss giant Roivant backs up…
November 16, 2020 - 3 minutes
Affimed
Cancer Immunotherapy Phase I on Hold After Patient Death
The German biotech Affimed has halted two Phase I trials of its cancer immunotherapy after…
October 10, 2018 - 2 minutes
What Cancer Therapies did European Biotechs Showcase at ASCO 2017?
Here are the most innovative therapies presented by European biotechs fighting cancer during the ASCO…
June 7, 2017 - 5 minutes
The ‘Formative Year’ of Germany’s only NASDAQ-listed Biotech
Affimed from Heidelberg had a 'formative year' (hmm) in 2015. Major highlights include raising of €52.6M,…
March 31, 2016 - 2 minutes
7 Trendy European Biotechs Listed on the NASDAQ in 2016
Here are 7 European Biotechs listed on the NASDAQ we thought were worth mentioning in more…
February 23, 2016 - 6 minutes
Keytruda Combo! MSD Recruits German Biotech on Lymphoma PD-1 Trial
Affimed in Heidelberg (Germany) will fund and conduct a clinical trial to investigate the combination of…
January 26, 2016 - 2 minutes
Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC
The World Leader in the Immuno-Oncology field has teamed up with a major German Investor…
November 24, 2015 - 2 minutes
Secret Shareholder racks up another €19.2M for Affimed’s Cancer Tandem Antibodies
Affimed Therapeutics is a clinical-stage biopharmaceutical company from Heidelberg (Germany) which is developing highly targeted…
October 19, 2015 - 2 minutes
Affimed secures almost $30M in Financing to continue its clinical development
Affimed Therapeutics today announced that it has closed a $15.7 million (€11.7 million) Series E…
September 3, 2014 - 2 minutes
